• xiaohongshu [none/use name]@hexbear.net
      link
      fedilink
      English
      arrow-up
      18
      ·
      23 days ago

      Weight loss treatment with GLP-1 is five times the dosage administered to diabetic patients.

      It is still far too early to tell if there are long term adverse effects to the people who take them at this level of dosage yet. It’s like taking 5 times the amount of drugs you normally would when prescribed by the physicians, and you have to keep taking them since the effect (lowering appetite and slowing food digestion) is reversible once you stop taking them.

      For clinically obese patients, the benefits of weight loss are probably going to outweigh the adverse consequences, but there have been many people who don’t meet the medical criteria and are taking them just for the sake of losing weight.

      • Hexboare [they/them]@hexbear.net
        link
        fedilink
        English
        arrow-up
        7
        ·
        23 days ago

        I understand that the dosages of semaglutide for diabetes range from 0.25mg to 2mg - are you saying people are injecting 10mg a week? That does seem like a considerable leap

        Th lifetime usage aspect makes them particularly attractive for pharma companies

        • xiaohongshu [none/use name]@hexbear.net
          link
          fedilink
          English
          arrow-up
          3
          ·
          edit-2
          23 days ago

          All SUSTAIN trials were performed at 0.5mg or 1.0mg, where glycemic control was largely achieved with 0.5mg dose, except for severe patients where lower dosage was inadequate to reach the HbA1c target.

          STEP trials for weight loss were done with 2.4mg per week, which is 5 times the dosage normally prescribed for Type 2 diabetes patients.

          • Hexboare [they/them]@hexbear.net
            link
            fedilink
            English
            arrow-up
            2
            ·
            23 days ago

            Yeah they did another trial (SUSTAIN FORTE) for diabetes after those

            Semaglutide is an effective treatment for type 2 diabetes; however, 20–30% of patients given semaglutide 1·0 mg do not reach glycaemic treatment goals. We aimed to investigate the efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in adults with inadequately controlled type 2 diabetes

            10.1016/S2213-8587(21)00174-1

            • xiaohongshu [none/use name]@hexbear.net
              link
              fedilink
              English
              arrow-up
              2
              ·
              edit-2
              22 days ago

              Yes, one trial in the last 5 years. Which is why I said we’re nowhere close to knowing the long term effect of these dosage. The first SUSTAIN goes back to 2014 and we have about a decade of data. All the STEP trials are within 5 years.

              You should also note that going from 1.0mg to 2.0mg (doubling the dosage) improved the HbA1c measure from 1.9% reduction to 2.1%. It’s statistically significant but the effect is also small (an improvement for treating severe patients but not so much for the rest of the disease population). Most of the reduction is in the body weight when increasing the dosage.

              • Hexboare [they/them]@hexbear.net
                link
                fedilink
                English
                arrow-up
                1
                ·
                22 days ago

                Right, but the weight loss increase was also very small

                Mean change in bodyweight from baseline at week 40 was −6·9 kg with semaglutide 2·0 mg and −6·0 kg with semaglutide 1·0 mg

                So glycated haemoglobin improves by 10 percent and weight loss increase by 15 percent.

                This would suggest to me that whatever long term problems are associated with semaglutide at 2mg are probably going to be associated with semaglutide at 1mg at broadly similar rates.

                Time will tell though!

    • RNAi [he/him]@hexbear.netOP
      link
      fedilink
      English
      arrow-up
      10
      ·
      23 days ago

      I don’t wanna be a -truther, I’m just paranoic of the thing being abused/misused cuz right now everyone is getting a prescription for it cuz it’s the magic treatment for weight loss.

      I just don’t want a Opioid Epidemic: Pancreas Shenanigangs Boogaloo

      • Hexboare [they/them]@hexbear.net
        link
        fedilink
        English
        arrow-up
        9
        ·
        23 days ago

        All drugs carry some level of risk, and there are enough rare side effects that you’d want a good reason to take anything, because otherwise you might end up as “Case Report: Rare instance of dissolved organs in 40 year old male treated with semaglutide for weight loss”, which would be unfortunate.